Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study
Go back to Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study| (NASDAQ: DTIL) | Delayed: 8.46 -0.39 (4.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.85 | 52 Week High | $ | |||
| Open | $8.82 | 52 Week Low | $ | |||
| Day High | $8.82 | P/E | N/A | |||
| Day Low | $8.41 | EPS | $ | |||
| Volume | 152,284 | |||||

